Acurx Pharmaceuticals reports Q4 2024 earnings results

to place undue reliance on these forward-looking statements. Robert Shawah welcomed participants to the call. He introduced David Luci, the company's CEO, who would provide an update on the business and future plans. After David's remarks, Robert planned to share highlights of the financial results for the last quarter and the full year 2024. The company released important financial data earlier in the day, which is accessible on their website. Robert reminded everyone that the call would include forward-looking statements, which carry risks and uncertainties. He urged investors to review the full details in their latest filings with the Securities and Exchange Commission. After this introduction, David Luci took the stage. He discussed the company's performance and what lies ahead for Acurx Pharmaceuticals. Following his update, Robert Shawah was expected to reveal specific financial figures and details. Finally, there would be time for questions from analysts and investors on the call.